Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

rHuEPO active in wound healing

Oct. 11, 2004

Novel melanogenesis inhibitors developed at Takasago

Oct. 8, 2004

Germany marks first European launch of Raptiva

Oct. 7, 2004

OraDisc A approved for aphthous ulcers

Oct. 7, 2004

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Pierre Fabre to commercialize Olux in Europe

Oct. 5, 2004

Approval sought for proof-of-concept study for ATL-1101 in psoriasis

Oct. 4, 2004

European approval for Raptiva for psoriasis

Sep. 30, 2004

Desilux enters phase III program for atopic dermatitis

Sep. 30, 2004

Non-approvable letter for oral tazarotene

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...